WebStealth BioTherapeutics Corp NAS :MITO (Cayman Islands) Portfolio $ 0.32 0 (0%) 09:42 AM EST Warning! GuruFocus has detected 1 Severe warning sign with MITO. Get your 7-Day Free Trial to check it out. Also Trade In: Volume: - Market Cap $: 23.54M PE Ratio: At Loss Avg Vol (2M): - Enterprise Value $: 3.48M PB Ratio: 0 Web15 nov. 2024 · Stealth BioTherapeutics Corp annonce la mise à jour des données du SBT-272 et la désign.. 2024: Départ du directeur financier de Stealth BioTherapeutics: 2024: …
STEALTH BIOTHERAPEUTICS CORP : MITO Stock Price
Web14 feb. 2024 · BOSTON – February 11, 2024 – Stealth BioTherapeutics Corp (Nasdaq:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that on February 11, 2024, it received a … WebCompany profile page for Stealth BioTherapeutics Corp including stock price, company news, press releases, executives, board members, and contact information symmetry around the world
Stealth BioTherapeutics Share Price - NMQ:MITO Stock Research
WebLatest Stealth BioTherapeutics Corp - ADR News: View MITO news and discuss market sentiment with the investor community on Public.com. ... ADR Stock (MITO) Stealth BioTherapeutics Announces Promotion of Marty Redmon to Chief Research & Development Officer. PRNewsWire • 03/16/21. Web30 mrt. 2024 · BOSTON, March 30, 2024 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel... WebFind the latest Stealth BioTherapeutics Corp. MITO analyst stock forecast, price target, ... MITO Stealth BioTherapeutics Corp. 0.3200 0.0000 (0.00%) As of 09:00PM . Market open. thachpham iptables